HOME >> MEDICINE >> NEWS
Antidepressant drug alleviates hot flashes in men undergoing prostate cancer treatment

ROCHESTER, MINN. -- Venlafaxine, an antidepressant drug, helps reduce the incidence of hot flashes in men undergoing androgen-deprivation therapy for prostate cancer, according to a recent Mayo Clinic report published in the Journal of Urology.

The researchers found that 10 out of 16 men (63 percent), had a greater than 50 percent reduction in hot flashes at the end of the fourth week of taking the antidepressant drug compared to a baseline week in which study participants took no drugs for hot flashes. The incidence of severe and very severe hot flashes in each patient was reduced from an average of 2.3 per day during the baseline week to an average of less than one per day at the end of the study.

"Approximately three out of four men who undergo androgen-deprivation therapy experience uncomfortable hot flashes", says Charles L. Loprinzi, M.D., Mayo Clinic medical oncologist and one of the authors of the study.

Information from this pilot study suggests that antidepressants such as venlafaxine offer the first effective non-hormonal treatment for hot flashes in men. Ongoing work is looking at various doses of venlafaxine and similar antidepressants to better determine the efficiency and toxicity of this approach.


'"/>

Contact: Mike O'Hara
e-mailnewsbureau@mayo.edu
507-284-9522 (days)
Mayo Clinic
3-Sep-1999


Page: 1

Related medicine news :

1. Antidepressants may increase risk of abnormal bleeding
2. Antidepressant may help people stop smoking when used with nicotine patch
3. Antidepressants are not safe for children
4. Antidepressants decrease chronic pain by inhibiting TNF production in brain, UB researchers find
5. Antidepressant drugs may protect brain from damage due to depression
6. Antidepressant provides a cool choice for hot flashes
7. Antidepressants impair cognitive function in the elderly
8. Antidepressants Can Lead To Mouth Infections
9. UF Psychiatrists Use Antidepressants To Treat Smoking Addiction
10. Rape Victims Find Relief From Posttraumatic Stress Using The Antidepressant Zoloft.
11. Immersion in virtual world alleviates pain from injury

Post Your Comments:
(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... virus that causes common cold sores -- herpes simplex -- ... Swedish researchers suggest. In fact, being a carrier of ... Alzheimer,s disease, the researchers found. "The identification of ... disorder is a breakthrough," said lead researcher Dr. Hugo Lovheim, ...
(Date:10/25/2014)... (HealthDay News) -- Researchers who discovered antibiotics in ... cause for concern. The use of antibiotics ... human consumption contribute to the development of antibiotic-resistant ... information from the study. Each year in ... million people and kill about 23,000, according to ...
(Date:10/25/2014)... (HealthDay News) -- Current osteoporosis screening guidelines and ... at risk for osteoporosis-related fractures, a new study ... we need tools that help us accurately predict ... we can target these at-risk people for preventive ... medicine in the division of general internal medicine ...
(Date:10/25/2014)... 24, 2014 (HealthDay News) -- October,s shorter, darker days ... affective disorder, according to an expert. People ... feel overly tired, lack motivation and even have trouble ... lead to suicide, said Dr. Angelos Halaris, a professor ... Loyola University Chicago Stitch School of Medicine. "Seasonal ...
(Date:10/22/2014)... 22, 2014 On Saturday, October 25, 2014, ... annual family health and fitness fair ¡Vive tu vida! Get ... and good nutrition for better health and wellness for people ... free and open to the public, will be held at ... 9:00 am to 1:00 pm. , “¡Vive tu Vida! ...
Breaking Medicine News(10 mins):Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
(Date:10/25/2014)... -- Burzynski Research Institute, Inc. (BRI) announced today that ... the company permission to conduct an open-label study of ... of age with a diffuse intrinsic brainstem glioma (DIPG). ... treatment groups based on their age and whether or ... primary study endpoint is a decrease in the size ...
(Date:10/22/2014)... 2014  Cephasonics, a technology-innovation leader with a game-changing ... (cQuest Ultrasound Box™-1), the first product in a new ... by Cephasonics for purchase by companies to rebrand with ... be showcasing the cQUB-1 for the first time at ... Chongqing, China from October 23 to ...
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
Breaking Medicine Technology:Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2
Cached News: